Uncategorized Archives - Page 202 of 248

MondayMar 19, 2018 1:26 pm

Marijuana Company of America, Inc. (MCOA) Creating a Diversified Range of Synergistic Opportunities in Hemp Sector

MCOA is involved in the production and distribution of high quality hemp-derived CBD products Company continues to add high-demand retail products Strategic investments and joint ventures offer broad-based opportunities In spite of all of the short-term political gyrations, the cannabis and hemp markets continue to bloom. The demand for cannabidiol (CBD) products remains persistent, and there are many attractive opportunities in the sector. Marijuana Company of America, Inc. (OTC: MCOA) is in position to thrive in spite of any short-term contortions in the cannabis and hemp markets. The company’s low-risk, high-return profile results from its focus on industrial hemp-based CBD…

MondayMar 19, 2018 11:54 am

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Details Cannabis Exportation Agreement for Sol-gel Research

Permits obtained for importation of cannabis into Australia PreveCeutical conducting research at University of Queensland for cannabinoid-based Sol-gel products Cannabis-based Sol-gel products targeted at relieving symptoms such as pain, inflammation, seizures and neurological disorders PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H), a health sciences company aiming to become a preventive health sciences leader, has announced the grant of three permits from the Australian government’s Department of Health allowing for the importation of cannabis into Australia for purposes of research. The permits, which have been granted to the Pharmacy Australia Centre of Excellence (PACE) at the University of Queensland,…

FridayMar 16, 2018 2:09 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Aims to Generate up to 80% of Revenues from Technology Licensing

CEO Chris Bunka says in audio interview that human study of company’s proprietary TurboCBD technology will start in April outside of North America Hopes to add 6-12 more IP technology licensing contracts within year Cutting-edge research designed to attract the attention of tobacco and cannabis industries Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) CEO Chris Bunka said in a recent audio interview that, although consumer products will always be important to LXRP, he estimates that up to 80 percent of its revenues could be generated through the licensing of its proprietary technology to other companies (http://cnw.fm/yT2HS). LXRP is a British…

FridayMar 16, 2018 12:53 pm

Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P) Readies Niche Products for Legal Cannabis Industry

Spending on legal cannabis worldwide expected to hit $57 billion by 2027 Canadian government preparing to legalize cannabis-infused edibles and beverages by mid-2019 Investments into cannabis-related companies topped $1.2 billion over first five weeks of 2018 Liberty Leaf Holdings Ltd. (CSE: LIB) (OTCQB: LIBFF) (FSE: HN3P), a vertically-integrated cannabis company with strategic investments in proven, revenue-generating businesses, is building a diversified portfolio that includes marketing a wide range of high quality, medicinal grade cannabis products with tremendous promise for both human and veterinary use. Liberty Leaf and its wholly owned subsidiary, North Road Ventures, recently signed an agreement with Cannabis…

ThursdayMar 15, 2018 4:10 pm

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Continues to Advance its Agenda

Owns worldwide rights for patented formulations and drug delivery technologies Develops and commercializes therapeutic pharmaceuticals and nutraceuticals Strategic agenda to become one of world’s only vertically integrated cannabis biotechs With worldwide rights for unique drug delivery platforms in place, Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is rapidly building a disruptive, vertically integrated biotechnology company. Advancing this agenda, the company recently announced that it has retained Cannabis Compliance Inc. to submit an application to Health Canada for a dealer’s license on behalf of Pivot’s acquisition target, Agro-Biotech Inc. (http://cnw.fm/0K5Xn). In February, Pivot announced that its entry into a…

ThursdayMar 15, 2018 1:46 pm

Global Payout Inc. (GOHE) Subsidiary’s Public Initial Blockchain Offering Showcases Company’s Fintech Capabilities

SEC-regulated offering of digital tokens Balance sheet funding program for fintech investments Issuer (MoneyTrac subsidiary) focused on fintech for cannabis industry With a public initial blockchain offering (“PIBCO”) now underway, Global Payout Inc. (OTC: GOHE) is showcasing its innovative prowess. A PIBCO is similar to an initial coin offering, except that the coins or tokens involved are treated as securities under federal laws. As a result, the rights and benefits represented by those digital assets are subject to SEC rules. Under the PIBCO, Global Payout’s majority-owned subsidiary, MoneyTrac Technology, Inc. (“MTRAC”), will offer tokens that provide share warrants of MoneyTrac…

ThursdayMar 15, 2018 12:50 pm

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Secures Australian Importation Permit in Support of Research into Sol-gels

Research will be conducted at PACE, a leading pharmaceutical research center in Australia PreveCeutical’s unique technology promises to be the first FDA-approved, CBD-based nose-to-brain delivery system using a Sol-gel platform Groundbreaking technology outstrips the benefits of any other delivery mechanism On March 13, 2018, PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) and Aurora Cannabis Inc. (OTCQB: ACBFF) (TSX: ACB) (FSE: 21P) announced that they had received three permits for the importation of cannabis plant material into Australia for research purposes. The permits were granted by the Australian Government’s Department of Health, allowing shipment from Canada by Aurora Cannabis…

WednesdayMar 14, 2018 3:40 pm

ChineseInvestors.com, Inc. (CIIX) CEO Discusses the Company’s Future on MoneyTV

Warren Wang, founder and CEO of ChineseInvestors.com (OTCQB: CIIX), was recently interviewed on MoneyTV with Donald Baillargeon. The company, in addition to being a leader in education products and services for the Chinese-speaking community in North America and elsewhere, has recognized and seized the opportunity in the growing cannabis industry. With a focus on cryptocurrency and financial education, as well as a new private company spinoff of its hemp assets, CIIX is a company to watch. Wang spoke of upcoming changes in both the cannabis and cryptocurrency markets. Anticipating the potential revenue of the company’s hemp assets for the 2018-2019…

WednesdayMar 14, 2018 1:59 pm

Medical Cannabis Payment Solutions’ (REFG) Green is Designed to Grow

Proprietary payment platform customized for legal cannabis merchants makes it a gateway to the industry for electronic money transactions CEO Jeremy Roberts says that Green platform takes state-sanctioned cannabis into the 21st century of electronic banking and financial services Green platform offers ease of cash management to merchants while enabling consumers and patients to purchase electronically, even with cryptocurrency Medical Cannabis Payment Solutions’ (OTC: REFG) Green platform, a top tier digital payment processing system, is designed to bring legalized cannabis and its cash management for licensed merchants and dispensaries into the world of digital financial services. “What we’re launching is…

WednesdayMar 14, 2018 12:12 pm

Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Completes $1.5 Million Private Placement

Proceeds to be used for development of new cultivation and processing project in New Brunswick A boost to operating capital Canada plans to legalize the extraction of cannabinoids from hemp in mid-2018 Market for hemp CBD products is predicted to grow to $450 million by 2020 Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF), a company focused on the cultivation of hemp and cannabinoid extraction for both domestic and international markets, announced on March 7, 2018, that it had closed a non-brokered private placement, consisting of 12.5 million units at a price of $0.12 per unit, to raise…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

Category: Uncategorized